Tag: as

NEW YORK and TORONTO, June 24, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “Helus Pharma”), a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), is pleased to announce the pricing of an underwritten offering of 10,309,280 common shares in the capital of the Company (the “Common Shares”) at an offering price of US$4.85 per Common Share, for aggregate gross proceeds of US$50 million (the “Offering”).

25th edition to feature leading voices in venture capital, energy, AI, and innovation, culminating in a sunset cruise on Lake Zurich and gala dinner at Rapperswil Castle

Company Announcement No 50/2026

Company Introduces Additional Review Procedures as Buyers Seek Greater Transparency Before Purchase

MUNICH, June 24, 2026 (GLOBE NEWSWIRE) -- Sigenergy (06656.HK), a leading innovator in smart solar energy and energy storage solutions, successfully hosted its New Product & Partner Ecosystem Launch Event during Intersolar Europe 2026. The exclusive gathering welcomed over 500 distributors, installers, and industry pioneers from across the globe, celebrating a new milestone in Sigenergy’s rapid global expansion and highlighting its foundational "AI in All" strategy. Under the theme "Innovating with AI, Growing with Partners", the company unveiled a full range of next-generation energy storage and solar products, and an upgraded global partner ecosystem.

DENVER, June 24, 2026 (GLOBE NEWSWIRE) -- Recently, SKHTU Exchange formally submitted its license application materials to the Monetary Authority of Singapore (MAS), marking the entry of the platforms compliance deployment in the Asian market into a substantive review phase. It is understood that the relevant application materials have completed preliminary acceptance, and the subsequent process will proceed to the document review and operational assessment stage in accordance with the regulatory procedures.